FI935724A0 - (S) (+) - 2-ethoxy-4- / N- / 1- (2-piperidinofenyl) -3-methyl-1-butyl / aminokarbonylmetyl / -bensoesyra - Google Patents
(S) (+) - 2-ethoxy-4- / N- / 1- (2-piperidinofenyl) -3-methyl-1-butyl / aminokarbonylmetyl / -bensoesyraInfo
- Publication number
- FI935724A0 FI935724A0 FI935724A FI935724A FI935724A0 FI 935724 A0 FI935724 A0 FI 935724A0 FI 935724 A FI935724 A FI 935724A FI 935724 A FI935724 A FI 935724A FI 935724 A0 FI935724 A0 FI 935724A0
- Authority
- FI
- Finland
- Prior art keywords
- piperidinofenyl
- bensoesyra
- aminokarbonylmetyl
- ethoxy
- butyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2111851 | 1991-06-21 | ||
SG1996002715A SG43036A1 (en) | 1991-06-21 | 1991-06-21 | (S) (+) -2-ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl- 1-buthyl]aminocarbony methyl] - benzoic a cid |
CA002111851A CA2111851C (en) | 1991-06-21 | 1991-06-21 | (s)(+)-2-ethoxy-4-[n-{1-(2-piperidino-phenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid |
EP9101147 | 1991-06-21 | ||
PCT/EP1991/001147 WO1993000337A1 (en) | 1991-06-21 | 1991-06-21 | (s)(+)-2-ethoxy-4-[n-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid |
SG9602715 | 1991-06-21 | ||
CN91104984A CN1048722C (en) | 1991-06-21 | 1991-07-22 | (S)(+)-2-Ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl-1-butyl]-aminocarbonylmethyl]-benzoic acid, pharmaceutical compositions containing compound and processes for preparation thereof |
CN91104984 | 1991-07-22 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI935724A0 true FI935724A0 (en) | 1993-12-20 |
FI935724A FI935724A (en) | 1993-12-20 |
FI106027B FI106027B (en) | 2000-11-15 |
Family
ID=36781542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI935724A FI106027B (en) | 1991-06-21 | 1993-12-20 | A process for the preparation of (S) (+) - 2-ethoxy-4- [N- [1- (2-piperidinophenyl) -3-methyl-1-butyl] aminocarbonylmethyl] -benzoic acid or its salt, and (S) -1- ( Preparation of N-acetyl-L-glutamine salt of 2-piperidinophenyl) -3-methyl-1-butylamine |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0589874B1 (en) |
JP (1) | JP2921982B2 (en) |
KR (1) | KR100496720B1 (en) |
CN (1) | CN1048722C (en) |
AU (1) | AU660930B2 (en) |
BG (1) | BG61690B1 (en) |
CA (1) | CA2111851C (en) |
DE (2) | DE59109151D1 (en) |
DK (2) | DK0965591T3 (en) |
FI (1) | FI106027B (en) |
GR (1) | GR3031654T3 (en) |
HK (1) | HK1011968A1 (en) |
NO (2) | NO303687B1 (en) |
PL (1) | PL170210B1 (en) |
RO (1) | RO113462B1 (en) |
SG (1) | SG43036A1 (en) |
SK (1) | SK281246B6 (en) |
UY (1) | UY25923A1 (en) |
WO (1) | WO1993000337A1 (en) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69800806T2 (en) | 1997-06-13 | 2001-09-13 | Novo Nordisk A/S, Bagsvaerd | NEW DOSAGE FOR DIABETES TYPE 2 |
IN192862B (en) | 1999-11-16 | 2004-05-22 | Ranbaxy Lab Ltd | |
PE20020617A1 (en) | 2000-08-22 | 2002-08-05 | Novartis Ag | COMPOSITION INCLUDING AN AT1 RECEPTOR ANTAGONIST AND AN INSULIN SECRETION POTENTIAL OR AN INSULIN SENSITIZER |
EP2316469A1 (en) | 2002-02-22 | 2011-05-04 | Shire LLC | Delivery system and methods for protecting and administering dextroamphetamine |
US20040102477A1 (en) * | 2002-08-23 | 2004-05-27 | Dr. Reddy's Laboratories Limited | Polymorphic forms of (S)-Repaglinide and the processes for preparation thereof |
US7915421B2 (en) * | 2003-05-14 | 2011-03-29 | Cilag Ltd. | Method for preparing phenyl acetic acid derivatives |
WO2004103983A1 (en) * | 2003-05-26 | 2004-12-02 | Biocon Limited | Process for the preparation of s(+)-2-ethoxy-4-[n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl]benzoic acid derivatives |
WO2005021524A1 (en) * | 2003-08-28 | 2005-03-10 | Ranbaxy Laboratories Limited | Process for the preparation of amorphous form of repaglinide |
CN1305863C (en) * | 2004-12-27 | 2007-03-21 | 浙江大学 | Method for synthesizing (S)-isopropyl-(2-piperidine) phenyl-methylhistamine |
GT200600381A (en) | 2005-08-25 | 2007-03-28 | ORGANIC COMPOUNDS | |
FR2898894B1 (en) * | 2006-03-24 | 2008-06-06 | Genfit Sa | SUBSTITUTED N- (PHENETHYL) BENZAMIDE DERIVATIVE COMPOUNDS, PREPARATION AND USES |
US7763607B2 (en) * | 2006-04-27 | 2010-07-27 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators |
MX2009004081A (en) * | 2006-10-20 | 2009-06-18 | Cpd Llc | Method of restoring the incretin effect. |
US8101769B2 (en) * | 2007-02-15 | 2012-01-24 | Actavis Group Ptc Ehf | Process for preparing ethyl (S)-2-ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonyl methyl]benzoate and use thereof for the preparation of Repaglinide |
US20100197732A1 (en) * | 2007-06-06 | 2010-08-05 | Actavis Group Ptc Ehf | Repaglinide Substantially Free of Dimer Impurity |
EP2019097A1 (en) | 2007-07-25 | 2009-01-28 | Aurobindo Pharma Limited | Process for preparing (alphaS)-alpha-(2-methylpropyl)-2-(1-piperidinyl)benzenemethanamine |
DK2200588T3 (en) | 2007-09-25 | 2019-07-01 | Solubest Ltd | COMPOSITIONS CONCERNING LIPOFILE ACTIVE RELATIONS AND METHOD OF PRODUCTION THEREOF |
DE102008046995B4 (en) * | 2008-09-12 | 2010-08-26 | Stada Arzneimittel Ag | 2-ethoxy-benzoic acid |
EP2177221A1 (en) | 2008-10-20 | 2010-04-21 | Krka Tovarna Zdravil, D.D., Novo Mesto | Process for the preparation of substantially optically pure Repaglinide and precursors thereof |
KR101338555B1 (en) | 2009-05-15 | 2013-12-09 | 노파르티스 아게 | Aryl pyridine as aldosterone synthase inhibitors |
CA2761853A1 (en) | 2009-05-15 | 2010-11-18 | Novartis Ag | Benzoxazolone derivatives as aldosterone synthase inhibitors |
KR20120041702A (en) | 2009-05-28 | 2012-05-02 | 노파르티스 아게 | Substituted aminobutyric derivatives as neprilysin inhibitors |
EA019511B1 (en) | 2009-05-28 | 2014-04-30 | Новартис Аг | Substituted aminopropionic derivatives as neprilysin inhibitors |
EP2993169B1 (en) | 2009-11-17 | 2017-12-20 | Novartis AG | Aryl-pyridine derivatives as aldosterone synthase inhibitors |
JO2967B1 (en) | 2009-11-20 | 2016-03-15 | نوفارتس ايه جي | Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors |
WO2011064376A1 (en) | 2009-11-30 | 2011-06-03 | Novartis Ag | Imidazole derivatives as aldosterone synthase inhibitors |
EP2364977A1 (en) | 2010-01-26 | 2011-09-14 | Reuter Chemische Apparatebau KG | Process for the enantiomeric enrichment of 3-methyl-1-(2-piperidinophenyl)-1-butylamine |
US8673974B2 (en) | 2010-11-16 | 2014-03-18 | Novartis Ag | Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors |
US8877815B2 (en) | 2010-11-16 | 2014-11-04 | Novartis Ag | Substituted carbamoylcycloalkyl acetic acid derivatives as NEP |
CN102267959B (en) * | 2011-07-06 | 2013-05-01 | 海南锦瑞制药股份有限公司 | Repaglinide crystal, preparation method thereof, and solid oral preparation containing same |
CN103012319B (en) * | 2011-09-20 | 2015-06-10 | 浙江九洲药业股份有限公司 | Repaglinide intermediate synthesis process improvement |
CN102584743A (en) * | 2011-12-28 | 2012-07-18 | 中国药科大学 | Dimethylaminopyridine repaglinide eutectic |
UY35144A (en) | 2012-11-20 | 2014-06-30 | Novartis Ag | APELINE SYNTHETIC LINEAR MIMETICS FOR THE CARDIAC INSUFFICIENCY TREATMENT |
EA028583B1 (en) | 2013-02-14 | 2017-12-29 | Новартис Аг | Substituted bisphenyl butanoic phosphonic acid derivatives as nep (neutral endopeptidase) inhibitors |
CN105612172A (en) | 2013-07-25 | 2016-05-25 | 诺华股份有限公司 | Cyclic polypeptides for the treatment of heart failure |
US9340582B2 (en) | 2013-07-25 | 2016-05-17 | Novartis Ag | Bioconjugates of synthetic apelin polypeptides |
US10034871B2 (en) | 2014-11-07 | 2018-07-31 | Regents Of The University Of Minnesota | Salts and compositions useful for treating disease |
MA41580A (en) | 2015-01-23 | 2017-11-29 | Novartis Ag | SYNTHETIC APELIN FATTY ACID CONJUGATES WITH IMPROVED HALF-LIFE |
WO2018034627A1 (en) | 2016-08-18 | 2018-02-22 | İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi | Pharmaceutical composition of antidiabetic tablet |
UY38072A (en) | 2018-02-07 | 2019-10-01 | Novartis Ag | COMPOSITIONS DERIVED FROM BUTANOIC ESTER SUBSTITUTED WITH BISPHENYL AS INHIBITORS OF NEP, COMPOSITIONS AND COMBINATIONS OF THE SAME |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3347565A1 (en) * | 1983-12-30 | 1985-07-11 | Thomae Gmbh Dr K | NEW PHENYL ACETIC DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
-
1991
- 1991-06-21 WO PCT/EP1991/001147 patent/WO1993000337A1/en active IP Right Grant
- 1991-06-21 RO RO93-01692A patent/RO113462B1/en unknown
- 1991-06-21 CA CA002111851A patent/CA2111851C/en not_active Expired - Lifetime
- 1991-06-21 DK DK99101810T patent/DK0965591T3/en active
- 1991-06-21 EP EP91911959A patent/EP0589874B1/en not_active Expired - Lifetime
- 1991-06-21 AU AU80781/91A patent/AU660930B2/en not_active Expired
- 1991-06-21 SG SG1996002715A patent/SG43036A1/en unknown
- 1991-06-21 KR KR1019930703974A patent/KR100496720B1/en active
- 1991-06-21 PL PL91301997A patent/PL170210B1/en unknown
- 1991-06-21 DK DK91911959T patent/DK0589874T3/en active
- 1991-06-21 DE DE59109151T patent/DE59109151D1/en not_active Expired - Lifetime
- 1991-06-21 SK SK1280-93A patent/SK281246B6/en not_active IP Right Cessation
- 1991-06-21 JP JP3511056A patent/JP2921982B2/en not_active Expired - Lifetime
- 1991-06-21 DE DE2000175006 patent/DE10075006I2/en active Active
- 1991-07-22 CN CN91104984A patent/CN1048722C/en not_active Expired - Lifetime
-
1993
- 1993-12-14 BG BG98300A patent/BG61690B1/en unknown
- 1993-12-20 NO NO934726A patent/NO303687B1/en not_active IP Right Cessation
- 1993-12-20 FI FI935724A patent/FI106027B/en not_active IP Right Cessation
-
1998
- 1998-12-08 HK HK98112967A patent/HK1011968A1/en not_active IP Right Cessation
-
1999
- 1999-07-20 NO NO1999017C patent/NO1999017I1/en unknown
- 1999-10-27 GR GR990402743T patent/GR3031654T3/en unknown
-
2000
- 2000-01-17 UY UY25923A patent/UY25923A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1068820A (en) | 1993-02-10 |
NO934726L (en) | 1993-12-20 |
CA2111851A1 (en) | 1993-01-07 |
DE59109151D1 (en) | 1999-10-14 |
AU660930B2 (en) | 1995-07-13 |
DE10075006I1 (en) | 2000-04-20 |
JP2921982B2 (en) | 1999-07-19 |
CN1048722C (en) | 2000-01-26 |
HK1011968A1 (en) | 1999-07-23 |
RO113462B1 (en) | 1998-07-30 |
KR100496720B1 (en) | 2006-01-27 |
CA2111851C (en) | 2002-02-26 |
EP0589874B1 (en) | 1999-09-08 |
DE10075006I2 (en) | 2004-01-08 |
NO1999017I1 (en) | 1999-07-20 |
JPH06508816A (en) | 1994-10-06 |
BG61690B1 (en) | 1998-03-31 |
WO1993000337A1 (en) | 1993-01-07 |
UY25923A1 (en) | 2001-08-27 |
GR3031654T3 (en) | 2000-02-29 |
SK281246B6 (en) | 2001-01-18 |
FI935724A (en) | 1993-12-20 |
EP0589874A1 (en) | 1994-04-06 |
FI106027B (en) | 2000-11-15 |
DK0965591T3 (en) | 2002-11-18 |
NO303687B1 (en) | 1998-08-17 |
SK128093A3 (en) | 1994-11-09 |
AU8078191A (en) | 1993-01-25 |
NO934726D0 (en) | 1993-12-20 |
SG43036A1 (en) | 1997-10-17 |
PL170210B1 (en) | 1996-11-29 |
BG98300A (en) | 1994-09-30 |
DK0589874T3 (en) | 2000-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI935724A (en) | (S) (+) - 2-ethoxy-4- / N- / 1- (2-PIPERIDINOFENYL) -3-methyl-1-BUTYL / AMINOKARBONYLMETYL / -BENSOESYRA | |
FI925526A0 (en) | CONTRAST MEASURES FOR ULTRALJUDSAVBILDNING | |
ATE137279T1 (en) | HEADCASE | |
ATA131391A (en) | REIBRING | |
DE4293023T1 (en) | Quick connection recording | |
FI934710A (en) | 4-Aryl-3- (HETEROARYLUREIDO) KINOLINDERIVAT | |
BR9202151A (en) | REPLACED IMIDAZOLINYLPYRIMIDINES | |
ITTO920878A0 (en) | VIOLIN | |
NO924464D0 (en) | DATA DEKOERINGSANORDNING | |
ATA39792A (en) | MAEHWERK | |
ATA170491A (en) | WALLSTONE | |
TR25953A (en) | SUBSTITUTED 2-ARILPIROLES | |
ATE163916T1 (en) | ETHYL-6-FORMYLOXY-4-HEXENOATE | |
FI911200A (en) | BESTAEMNINGSMETOD | |
ATA67791A (en) | ROLLSKI | |
ATA9892A (en) | FORMSTEIN | |
TR26694A (en) | SUBSTITUTED 4-HETARIL-PIRAZOLINES | |
BR9205291A (en) | PENTANOI REPLACED | |
ES1018290Y (en) | TABLE-FRIDGE | |
KR930002463U (en) | Case | |
ATA3092A (en) | SCOPE | |
ATA90791A (en) | MANCHON | |
BR9100265A (en) | MULTIUTILITARY BREADER | |
BR7100443U (en) | VIGIER | |
BR7102423U (en) | MIC-LAV |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer of assignment of patent |
Owner name: NOVO NORDISK A/S Free format text: NOVO NORDISK A/S |
|
MA | Patent expired |